Prognostic relevance of pancreatic uptake of technetium-99m labelled human polyclonal immunoglobulins in patients with type 1 diabetes

European Journal of Nuclear Medicine

Volumn 25, Issue 5, 1998, Pages 503-508

  Barone, Raffaella ^a   Procaccini, Enrica ^a   Chianelli, Marco ^a   Annovazzi, Alessio ^a   Fiore, Vincenzo ^e   Hawa, Mohammed ^b   Nardi, Giampaolo ^a   Ronga, Giuseppe ^a   Pozzilli, Paolo ^b,c   Signore, A ^e   Pozzilli, P ^e   Visalli, N ^e   Baroni, M G ^e   Buzzetti, R ^e   Nistico L ^e   Fioriti, E ^e   Mesturino, C ^e   Valente, L ^e   Cavallo, M G ^e   Multari, G ^e   Suppa, M A ^e   De Mattia, G C ^e   Cassone Faldetta, M ^e   Laurenti, O ^e   Lucentini, L ^e   Matteoli, M C ^e   Crino A ^e   Teodonio, C ^e   Amoretti, R ^e   Ruggeri, M ^e   Tombesi, M ^e   Pisano, L ^e   Pennafina, M G ^e   Suraci, C ^e   Boscherini, B ^e   Fonte, M T ^e   Manca Bitti, M L ^e   Stoduto, S ^e   Marietti, G ^e   Ferrazzoli, F ^e   Bizzarri, C ^e   Pitocco, F ^e   Ghirlanda, G ^e   more..

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^d POLICLINICO UMBERTO I   (Italy)

^e NONE

Author keywords

Inflammation; Insulin dependent diabetes; Insulitis; Radiolabelled immunoglobulins

Indexed keywords

IMMUNOGLOBULIN; TECHNETIUM 99M;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GAMMA SCINTIGRAPHY; HUMAN; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; ISOTOPE LABELING; MALE; PANCREAS; PROGNOSIS; RADIOACTIVITY; REMISSION;

CELLS; CYTOLOGY; INSULIN; NUCLEAR MEDICINE; PATHOLOGY;

BETA CELL; BETA CELL FUNCTIONS; DEPENDENT DIABETES; DEPENDENT TYPES; INFLAMMATION; INSULITI; POLYCLONAL; RADIOLABELED IMMUNOGLOBULIN; TECHNETIUM-99M; TYPE 1 DIABETES;

DIAGNOSIS;

EID: 15644365900     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050250     Document Type: Article

References (23)

1. Atkinson MA, Maclaren NK. The pathogenesis of insulin dependent diabetes mellitus. N J Engl Med 1994; 331: 1428-1436.
2. Todd JA. Genetics of type 1 diabetes using whole genome approaches. Proc Natl Acad Sci USA 1995; 92: 8560-8565.
3. Verge CF, Gianiani R, Kawasaki E, et al. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 1996; 45: 926-933.
4. Foulis AK, Liddle CN, Farquharson MA, Richmond JA, Weir RS. The histopathology of the pancreas in type I (insulin-dependent) diabetes mellitus: a 25 year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 1986; 29: 267-274.
5. Srikanta S, Ganda OP, Gleason RE, Jackson RA, Soeldner JS, Eisenbarth GS. Pre-type 1 diabetes: linear loss of cell response to intravenous glucose. Diabetes 1984; 33: 717-720.
6. Rossini AA, Greiner DL, Friedman HP, Mordes JP. Immunopathogenesis of diabetes mellitus. Diabetes Rev 1993; 1: 43-75.
7. Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PGF, Gamble DR. In situ characterisation of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 1985; 313: 353-360.
8. Pipeleers D, Ling Z. Pancreatic beta cells in insulin-dependent diabetes. Diabetes Metab Rev 1992; 8: 209-227.
9. Hanafusa T, Miyazaki A, Miyagawa J, et al. Examination of islets in the pancreas biopsy specimens from newly diagnosed type I (insulin dependent) diabetic patients. Diabetologia 1990; 33: 105-111.
10. Pozzilli P, Maclaren NK. Immunotherapy at clinical diagnosis of insulin-dependent diabetes. Trends Endocrinol Metab 1993; 4: 101-105.
11. Pozzilli P, Visalli N, Signore A, et al. Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study). Diabetologia 1995; 38: 848-852.
12. Pozzilli P, Browne PD, Kolb H, The Nicotinamide Trialists. Meta-analysis of nicotinamide treatment in patients with recent-onset IDDM. Diabetes Care 1996; 19,12: 1357-1361.
13. 99mTc monoclonal antibodies for imaging chronic osteomyelitis. Eur J Nucl Med 1991; 18: 401-407.
14. Berna L, Torres G, Diez C, et al. Technetium-99 m human polyclonal immunoglobulin G studies and conventional bone scans to detect active joint inflammation in chronic rheumatoid arthritis. Eur J Nucl Med 1992; 19: 173-176.
15. Stoeger A, Mur E, Penz-Schneeweiss D, et al. Technetium 99m human immunoglobulin scintigraphy in psoriatic arthropathy: first results. Eur J Nucl Med 1994; 21: 342-344.
16. Fischman AJ, Rubin RH, White AA, et al. Localization of Fc and Fab fragments of nonspecific polyclonal IgG at focal sites of inflammation. J Nucl Med 1990; 31: 1199-1205.
17. 99Tcm-HIG in rheumatoid arthritis. Nucl Med Communications 1996; 17: 523-528.
18. Schmidli RS, Colman PG, Bonifacio E, Participating Laboratories. Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. Diabetes 1995; 44: 636-640.
19. Lan MS, Wasserfell C, MacLaren NK, Notkins AL. IA-2; a transmembrane protein of the protein tyrosine phosphatase, is a major autoantigen in insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1996; 93: 6367-6370.
20. 99mTc labelled radiopharmaceuticals. Eur J Nucl Med 1989; 15: 174-179.
21. Huda W, Atherton JV, Ware DE, Cumming WA. An approach for the estimation of effective radiation dose at CT in pediatric patients. Radiology 1997; 203: 417-422.
22. Kaldany A, Hill T, Wentworth S, Brink SJ, D'Elia JA, Clouse M, Soeldner JS. trapping of peripheral blood lymphocytes in the pancreas of patients with acute-onset insulin-dependent diabetes mellitus. Diabetes 1982; 31: 463-466.
23. 123I-Interleukin-2 scintigraphy: a new approach to assess disease activity in autoimmunity. J Pediatr Endocrinol Metab 1996; 9: 139-144.